Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615774-15-001605
Filing Date
2015-06-25
Accepted
2015-06-25 17:25:32
Documents
1
Period of Report
2015-06-15

Document Format Files

Seq Description Document Type Size
1 3 s101382_form3.html 3  
1 3 s101382_form3.xml 3 2817
  Complete submission text file 0001615774-15-001605.txt   4283
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address FALLMERAYER STR. 19 MUNICH 2M 80796
Business Address
Thomas Steffen (Reporting) CIK: 0001646396 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51652 | Film No.: 15952544